S

Stemgent

14 employees

Stemgent is a provider of reagents, services and training for scientists who study cellular reprogramming (iPS cells).

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Compound profiling services in cell-based assays
mRNA reprogramming systems and services
Reagents for pluripotent cell culture and differentiation
Global supplier of human tissue and biofluids
Search Engine
Target and biomarker validation services
Human Resources

Date founded

2007

Funding rounds raised

Total raised

$14M

from 7 investors over 7 rounds

S

Stemgent raised $11M on June 10, 2011

Investors: HealthCare Ventures LLC and Morgenthaler

S

Stemgent raised $2.7M on November 25, 2009

Investors: Morgenthaler

S

Stemgent raised $14M on March 1, 2009

Investors: Frazier Healthcare Partners and Morgenthaler

S

Stemgent raised $6.5M on July 18, 2008

Investors: HealthCare Ventures LLC and Morgenthaler

FAQ